Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer

NCT04840472 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04840472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04840472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Suspended
Start date
March 30, 2021
Completion date
March 31, 2027
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer